Self-inflicted cardiac injury  : he "nailed" it - Bouhdadi H, Benlafqih C, Wazaren H, Nadhil M, Rhissassi J, Sayah R, Laaroussi M.
We report the case of a... (Source: SafetyLit)
Source: SafetyLit - January 9, 2023 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Pediatric aortic injury from a BB gun injury requiring emergent thoracotomy - Sunderland M, Lafranchise E, Durrant A.
We present a case of a 10-ye... (Source: SafetyLit)
Source: SafetyLit - April 25, 2022 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Performance and outcome evaluation of emergency resuscitative thoracotomy in a Norwegian trauma centre: a population-based consecutive series with survival benefits - Thorsen K, Vetrhus M, Narvestad JK, Reite A, Larsen JW, Vennesland J, Tjosevik KE, S øreide K.
BACKGROUND: Emergency resuscitative thoracotomy (ERT) is a lifesaving procedure for select indications in severely injured patients. The main body of the literature stem from regions with a high prevalence of penetrating injuries, while data from European ... (Source: SafetyLit)
Source: SafetyLit - June 17, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Outcomes following resuscitative thoracotomy for abdominal exsanguination, a systematic review - Hughes M, Perkins Z.
BACKGROUND: Resuscitative thoracotomy is a damage control procedure with an established role in the immediate treatment of patients in extremis or cardiac arrest secondary to cardiac tamponade however Its role in resuscitation of patients with abdominal ex... (Source: SafetyLit)
Source: SafetyLit - February 11, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Meet the Brilliant Minds Behind the First ICD
Mirowski: From WWII to Sinai Hospital The story of how Mieczyslaw "Michel" Mirowski ended up in America where he conceived the idea of an implantable cardioverter-defibrillator (ICD) is almost as incredible as the invention itself, if not more so. Mirowski was born in Warsaw, Poland in 1924. He grew up among the large Jewish population of Warsaw at that time, but when the Nazis invaded Poland in 1939, 15-year-old Mirowski left his family and fled to Russia with a friend. He would be the only member of his family to survive World War II, according to a 2010 article...
Source: MDDI - February 3, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Implants Source Type: news

Medtronic is Moving Toward a Fully-Implantable LVAD
Medtronic is developing a fully-implantable left ventricular assist device. The Dublin-based company announced Tuesday it had received breakthrough device designation for the technology. Current LVAD systems, including the HVAD Medtronic inherited when it acquired HeartWare International for $1.1 billion in 2016, are connected to a driveline cable that extends outside the body to a controller. This is then connected to power sources (AC or DC adapter, batteries). Medtronic’s new LVAD is being designed to be fully implanted inside the body. News of the development of the new LVAD system comes a little more...
Source: MDDI - October 31, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Regulatory and Compliance Source Type: news

How Did Medtronic ’s HVAD Perform in LATERAL Trial?
Medtronic’s HeartWare HVAD pump system could get a significant boost after performing well in the LATERAL clinical trial. The Dublin-based company presented results from the study at the American Society for Artificial Internal Organs 65th Annual Conference, that showed patients who received the system had 95% freedom from disabling stroke at two years. The medtech giant now plans to launch a global registry to collect additional clinical evidence to further characterize survival, adverse events, and economic benefits of the HVAD System. The HVAD Pump is a left ventricle assist device (LVAD) approved in t...
Source: MDDI - July 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Medtronic touts stroke data from HeartWare HVAD thoracotomy study
Medtronic (NYSE:MDT) today touted stroke data from the Lateral trial of its HeartWare HVAD left ventricular assist device involving implantation via thoracotomy instead of open surgery. With a thoracotomy implantation, surgeons insert the pump via a small, lateral incision between the left ribs and make a second small incision to accommodate the pump’s outflow graft. Fridley, Minn.-based Medtronic said Lateral results presented at the annual meeting of the American Society for Artificial Internal Organs showed that 95% of thoractomy patients were free from disabling stroke at two years. Adverse events were more like...
Source: Mass Device - July 8, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Cardiac Assist Devices Cardiovascular Clinical Trials Featured Medtronic Source Type: news

New technique for minimally invasive lung cancer surgery -- ultrasonic device safe, effective
(American Association for Thoracic Surgery) According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of thoracotomy conversion for VATS/robotic anatomical lung resection. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 4, 2019 Category: Cancer & Oncology Source Type: news

Medtronic touts economic data for HeartWare HVAD
Medtronic (NYSE:MDT) today touted more data on the HeartWare left-ventricular assist device it acquired in 2016, saying economic analyses of prior trials showed its cost effectiveness. The Fridley, Minn.-based medical device giant said one analysis, of data from the Lateral thoracotomy study showed that patients implanted with its HVAD pump incurred lower hospitalization and medical supply costs than patients implanted via sternotomy. The average total cost per thoracotomy patient was $204,107, compared with $260,492 for traditional median sternotomy. Lateral also showed an 87% survival rate at two years and a 30% in leng...
Source: Mass Device - April 8, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Cardiac Assist Devices Clinical Trials Featured Medtronic Source Type: news

Belgian EPP Study Shows Mesothelioma Surgery Extends Survival
Using proper patient selection, doctors in Leuven, Belgium, are extending mesothelioma survival times significantly with the controversial extrapleural pneumonectomy surgery. Despite a growing reluctance to perform the surgery within the United States and throughout much of Europe, mesothelioma specialists at University Hospitals KU Leuven have continued performing it with great success. Their 2018 single-center study of the extrapleural pneumonectomy (EPP) for pleural mesothelioma produced a 33.2-month median survival and a 24.2 percent five-year survival. “With our dedicated team, a patient can do well with this surger...
Source: Asbestos and Mesothelioma News - March 4, 2019 Category: Environmental Health Authors: Walter Pacheco Source Type: news

What Are the Types of Tracheoesophageal Fistulas?
Discussion Respiratory problems in infants can caused by many things including any type of obstruction from the nose to lung. Neonates and infants are particularly susceptible to changes in the size of the airway because of the physics of airflow resistance. Important reminders about infant airways: Resistance = 1/radius4 (Poiseuille’s equation) therefore even a 1 mm decrease in the airway circumferences increases the airflow resistance x16. Increased airflow causes less pressure along the walls, which can lead to collapse of the walls (Bernoulli’s and Venturi effects). Neonates have smaller lungs relative to ...
Source: - March 4, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Medtronic wins expanded FDA nod for SelectSure pacing leads
Medtronic (NYSE:MDT) said today it won expanded FDA labeling for its SelectSecure MRI SureScan model 3830 cardiac pacing leads, now approved for His-bundle pacing. The Fridley, Minn.-based company said its bipolar, steroid-eluting SelectSecure leads are designed to be attached to a single or dual chamber pace maker and are now approved for pacing and sensing in the atrium, right ventricle or at the bund of HIS as an alternative to right ventricular placing. Medtronic said it also offers a C315HIS deliver catheter for placing leads at or near the His bundle. “There is growing interest among some physicians in His-bun...
Source: Mass Device - July 12, 2018 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Food & Drug Administration (FDA) Regulatory/Compliance Medtronic Source Type: news

Medtronic ’s HVAD System Just Became Less Invasive
Medtronic has gained FDA approval for a less-invasive implant approach of its HVAD System, a left ventricular assist device (LVAD) for advanced heart failure patients. The Dublin-based company picked up the technology when it acquired HeartWare in 2016. The firm said the technology is the only LVAD approved in the U.S. for implant via thoracotomy, a small lateral, surgical incision between the patient's ribs on the left side of the chest. FDA approval for HVAD implantation via thoracotomy is based on data from the LATERAL prospective clinical trial, in which 144 patients, with end-stage heart failure who were eligible for ...
Source: MDDI - July 12, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

FDA Approves HeartWare LVAD for Implant via Thoracotomy FDA Approves HeartWare LVAD for Implant via Thoracotomy
Implanting Medtronic ' s HeartWare ventricular assist device via the less invasive approach was shown to be safe and effective in the LATERAL clinical trial.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 11, 2018 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news